AMS:LSE-Advanced Medical Solutions Group plc (GBX)

COMMON STOCK | Medical Instruments & Supplies | LSE

Last Closing Price

GBX 267.00

Change

0.00 (0.00)%

Market Cap

GBX 0.59B

Volume

0.21M

Avg Analyst Target

N/A

Avg User Target

GBX
Average Analyst Rating

N/A

Fundamental Analysis

Verdict


AMS Stock Forecast & Price:
Based on the Advanced Medical Solutions Group plc stock forecasts from 0 analysts, the average analyst target price for Advanced Medical Solutions Group plc is not available over the next 12 months. Advanced Medical Solutions Group plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Advanced Medical Solutions Group plc is Slightly Bullish , which is based on 9 positive signals and 6 negative signals. At the last closing, Advanced Medical Solutions Group plc’s stock price was GBX 267.00. Advanced Medical Solutions Group plc’s stock price has changed by -1.84% over the past week, -2.20% over the past month and -16.95% over the last year.

No recent analyst target price found for Advanced Medical Solutions Group plc
No recent average analyst rating found for Advanced Medical Solutions Group plc

About Advanced Medical Solutions Group plc (AMS:LSE)

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-12-08 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CTEC:LSE ConvaTec Group PLC

-1.40 (-0.61%)

GBX4.73B 76.33 16.67
TSTL:LSE Tristel

N/A

GBX0.17B 180.00 37.37
BVC:LSE Batm Advanced Communications L..

-0.35 (-1.64%)

GBX0.10B N/A 6.72
SPEC:LSE Inspecs Group plc

N/A

GBX0.05B N/A 5.20
ODX:LSE Omega Diagnostics Group Plc

N/A

GBX7.96M 16.43 -8.85

ETFs Containing AMS

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Instruments & Supplies)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.01% 67% D+ 37% F
Dividend Return 0.01% 33% F 10% F
Total Return -21.00% 67% D+ 37% F
Trailing 12 Months  
Capital Gain -18.60% 83% B 41% F
Dividend Return 0.01% 33% F 9% F
Total Return -18.59% 83% B 40% F
Trailing 5 Years  
Capital Gain -17.02% 40% F 32% F
Dividend Return 1.29% 50% F 11% F
Total Return -15.72% 40% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain -0.80% 17% F 43% F
Dividend Return 0.32% 50% F 32% F
Total Return -0.48% 17% F 43% F
Risk Return Profile  
Volatility (Standard Deviation) 20.79% 100% A+ 45% F
Risk Adjusted Return -2.29% 17% F 44% F
Market Capitalization 0.59B 83% B 60% D-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Instruments & Supplies)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 33.19 75% C 13% F
Price/Book Ratio 2.68 50% F 24% F
Price / Cash Flow Ratio 19.01 33% F 18% F
EV/EBITDA 15.86 50% F 15% F
Management Effectiveness  
Return on Equity 8.55% 100% A+ 48% F
Return on Invested Capital 8.92% 83% B 79% C+
Return on Assets 5.99% 83% B 73% C
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Dividend Yield 0.75% 20% F 34% F
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.63 67% D+ 79% C+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.